Skip to main content
Premium Trial:

Request an Annual Quote

FDA Clears Idaho's Q Fever MDx Test

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Food and Drug Administration today cleared the first nucleic acid amplification test for the diagnosis of Q fever infection in military personnel serving overseas.

The test, which was developed by Idaho Technology, was funded by the Chemical Biological Medical System Joint Project Management Office within the US Department of Defense, and identifies and detects the bacteria that cause Q fever, or Coxiella burnetii. It does so by determining whether Coxiella burnetii DNA is present in a patient's blood sample. Results can be achieved within four hours, FDA said.

FDA cleared the test for use on DOD's Joint Biological Agency Identification and Diagnostic System, or JBAIDS, a multiple use platform for the rapid detection of bacteria and viruses. Use of the test is limited to designated DOD laboratories equipped with JBAIDS.

FDA said that Q fever is an emerging infectious disease among servicemen and servicewomen in Iraq and worldwide. It can cause acute or chronic illness and is acquired primarily from contact with infected animals or exposure to contaminated environments. Early treatment with antibiotics normally leads to full recovery.

The disease was first recognized as a human disease in Australia in 1935 and in the US in early 1940s. The "Q" stands for "query," FDA said, as the causative agent was unknown at the time.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.